BIOMAT Database Logo BIOMAT Database Logo

Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current. 1995

R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Biomedical Department, National Academy of Sciences of Ukraine.

Effects of chlorpromazine, haloperidol (neuroleptics and calmodulin antagonists), and verapamil on rat platelet aggregation induced by thrombin, on calcium current in snail neurones and on both tonic tension of high potassium contracture and phasic contraction of isolated guinea-pig ureter preparations were studied. Moreover, droperidol, sulpiride and prazosine effects were studied for models of phasic contractility and platelet aggregation. Sulpiride and prazosine were ineffective, verapamil was ineffective on platelet aggregation, while droperidol was the most potent inhibitor of platelet aggregation. These results, the similarity revealed in the blockage of neuronal calcium current by neuroleptics and verapamil, and the potent inhibitory action of haloperidol and chlorpromazine on contractility and aggregation suggest that both phenothiazine and butyrophenone neuroleptics possess some properties of calcium antagonists and may also have intracellular sites of action other than calmodulin.

UI MeSH Term Description Entries
D007537 Isometric Contraction Muscular contractions characterized by increase in tension without change in length. Contraction, Isometric,Contractions, Isometric,Isometric Contractions
D008297 Male Males
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D002090 Butyrophenones Compounds containing phenyl-1-butanone.
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium

Related Publications

R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Long-term regulation of contractility and calcium current in smooth muscle.
November 1997, The American journal of physiology,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
[Calcium regulation of smooth muscle contractility].
December 1990, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Calcium control of smooth muscle contractility.
October 1988, The American journal of the medical sciences,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Calcium and contractility in depolarized smooth muscle.
April 1960, Nature,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Quinine and lanthanum effects on contractility and calcium movements of rat ileal smooth muscle.
January 1977, General pharmacology,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Selective inhibitory effects of chlorpromazine and imipramine on platelet aggregation.
January 1980, International pharmacopsychiatry,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
CALCIUM AND THE CONTRACTILITY OF ARTERIAL SMOOTH MUSCLE.
January 1964, The American journal of physiology,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Effects of calcium antagonists on spontaneous and pharmacologically increased contractility of vascular smooth muscle.
May 1983, Archives internationales de pharmacodynamie et de therapie,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
The effects of EGTA on vascular smooth muscle contractility in calcium-free medium.
August 1988, Canadian journal of physiology and pharmacology,
R A Prokopenko, and S E Mogilevich, and A I Luik, and I Y Naydyenova, and G N Batrak, and B R Hawryluk, and V Y Degtiar
Calcium regulation in vascular smooth muscle contractility.
January 1987, The American journal of cardiology,
Copied contents to your clipboard!